Interest in TRAP1 has considerably grown in recent decades due to its contextual effects in different tumor types: it is highly expressed in several cancers and correlated with drug resistance, but is downregulated in specific tumors with predominant oxidative metabolism [6]. This evidence concerns the gene TRAP1 and neoplasm.